Canakinumab Subcutaneous and Prochieve (Progesterone Vaginal 8% Gel)
Determining the interaction of Canakinumab Subcutaneous and Prochieve (Progesterone Vaginal 8% Gel) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: progesterone
Brand name: Crinone, Endometrin, FIRST-Progesterone VGS 200, Prochieve, First Progesterone MC10, Menopause Formula Progesterone, Prometrium
Synonyms: Prochieve
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Prochlorperazine
- Canakinumab Subcutaneous-Prochlorperazine Edisylate
- Canakinumab Subcutaneous-Prochlorperazine Injection
- Canakinumab Subcutaneous-Prochlorperazine Maleate
- Canakinumab Subcutaneous-Prochlorperazine rectal
- Canakinumab Subcutaneous-Prochlorperazine Suppositories
- Prochieve (Progesterone Vaginal 8% Gel)-Canasa
- Prochieve (Progesterone Vaginal 8% Gel)-Canasa Pac rectal
- Prochieve (Progesterone Vaginal 8% Gel)-Canasa rectal
- Prochieve (Progesterone Vaginal 8% Gel)-Cancidas
- Prochieve (Progesterone Vaginal 8% Gel)-Candesartan
- Prochieve (Progesterone Vaginal 8% Gel)-Candesartan and Hydrochlorothiazide